Fukazawa T, Kikuchi S, Miyagishi R, Miyazaki Y, Yabe I, Hamada T, Sasaki H
Hokuyukai Neurology Hospital, Niju-Yon-Ken 2-2-4-30, Nishi-ku, Sapporo 063-0802, Japan.
Mult Scler. 2006 Feb;12(1):19-23. doi: 10.1191/135248506ms1252oa.
Apart from its unique lesion distribution pattern, the opticospinal form of multiple sclerosis (OSMS) is distinct among Japanese patients who satisfy the diagnostic criteria of MS. OSMS has been suggested to be strongly associated with HLA-DPB10501 in Japanese. However, association of DPB10301 with non-OSMS and lack of DPB10301 in OSMS were also reported. To verify the role of DPB10501 and DPB10301 in Japanese MS patients we determined the frequencies of these alleles in 26 patients with OSMS, 167 with non-OSMS and 156 normal subjects, who were all residents of Hokkaido, the northernmost island of Japan. All (100%) OSMS were negative for DPB10301 while 32 (19%) of the non-OSMS were positive for the allele. In DPB10301-negatives, the frequencies of DPB10501 in OSMS (85%) and non-OSMS (82%) were similar, but both were higher than in the controls (66%). In DPB10301-positives, the frequency of DPB10501 was low but similar in non-OSMS (12/32; 38%) and controls (6/14; 43%). Periventricular white matter lesions (PVL) were noted in 31 of 32 (97%) DPB10301-positive non-OSMS patients but in only 22 out of 135 (16%) DPB10301-negative non-OSMS patients and two out of 26 (8%) OSMS patients. Our findings indicate that DPB10501 plays an important role in the development of MS in general, but not in OSMS. The strong association of DPB10501 with OSMS may be due to the over-representation of the DPB10301 allele among individuals in the non-OSMS group. In addition, DPB10301 might be relevant to the development of periventricular lesions in Japanese patients with MS.
除了其独特的病变分布模式外,视神经脊髓型多发性硬化症(OSMS)在符合多发性硬化症诊断标准的日本患者中也很独特。在日本,OSMS被认为与HLA - DPB10501密切相关。然而,也有报道称DPB10301与非OSMS相关,且OSMS中缺乏DPB10301。为了验证DPB10501和DPB10301在日本多发性硬化症患者中的作用,我们测定了26例OSMS患者、167例非OSMS患者和156名正常受试者(他们均为日本最北部岛屿北海道的居民)中这些等位基因的频率。所有(100%)OSMS患者的DPB10301均为阴性,而非OSMS患者中有32例(19%)该等位基因为阳性。在DPB10301阴性患者中,OSMS患者(85%)和非OSMS患者(82%)的DPB10501频率相似,但两者均高于对照组(66%)。在DPB10301阳性患者中,DPB10501频率较低,但在非OSMS患者(12/32;38%)和对照组(6/14;43%)中相似。32例DPB10301阳性的非OSMS患者中有31例(97%)出现脑室周围白质病变(PVL),而135例DPB10301阴性的非OSMS患者中只有22例(16%)出现PVL,26例OSMS患者中只有2例(8%)出现PVL。我们的研究结果表明,DPB10501总体上在多发性硬化症的发病中起重要作用,但在OSMS中并非如此。DPB10501与OSMS的强关联可能是由于非OSMS组个体中DPB10301等位基因的比例过高。此外,DPB10301可能与日本多发性硬化症患者脑室周围病变的发生有关。